This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): KaroMab-GEX
Description: KaroMab-Gex is an antibody (GlycoBody) against a carbohydrate antigen on the tumor marker, MUC1. GlycoBodies are designed to recognize protein targets with specific post-translational modifications that are only present on tumor cells and not on normal cells.
Additional information available to subscribers only: